百济神州Q1营收增长50.2%至80.48亿元,百悦泽®全球销售额总计56.92亿

财经网
07 May

5月7日,百济神州发布2025年一季报。披露公司Q1营收增长50.2%至80.48亿元,净亏损9450.3万元。其中,公司Q1产品收入为79.85亿元,较上年同比上升49.9%;产品收入的增长主要得益于公司自研产品百悦泽®(泽布替尼胶囊),以及百泽安®(替雷利珠单抗)和安进授权产品的销售增长。2025年第一季度,百悦泽®全球销售额总计56.92亿元,同比增长63.7%,在血液肿瘤领域进一步巩固领导...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10